Our study demonstrates that PREP disruption dynamically ameliorates hepatic steatosis and inflammation by regulating intestinal dysbiosis, activating the AMPK/SIRT1 pathway, and inhibiting the inflammatory signaling pathway. The gene discussed is SIRT1; the disease is Hepatic steatosis.